Eosinophilic myositis/perimyositis: Frequency and spectrum of cutaneous manifestations

Hall, 1993, Hypereosinophilic syndromes: association with vasculitis, fibrosis and autoimmunity, Clin Exp Allergy, 23, 542, 10.1111/j.1365-2222.1993.tb00892.x Hardy, 1968, The hypereosinophilic syndromes, Ann Intern Med, 68, 1220, 10.7326/0003-4819-68-6-1220 Chusid, 1975, The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature, Medicine (Baltimore), 54, 1, 10.1097/00005792-197501000-00001 Silver, 1992, Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia, Curr Opin Rheumatol, 4, 851 Gleich, 1984, Episodic angioedema associated with eosinophilia, N Engl J Med, 310, 1621, 10.1056/NEJM198406213102501 Kaufman, 1993, The spectrum of eosinophilic myositis, Arthritis Rheum, 36, 1014, 10.1002/art.1780360720 Roberts, 1975, Masticator myopathy in the dog, Vet Med Small Anim Clinician, 70, 840 Trüeb, 1995, Relapsing eosinophilic perimyositis, Br J Dermatol, 133, 109, 10.1111/j.1365-2133.1995.tb02502.x Trüeb, 1997, Eosinophilic myositis with eosinophilic cellulitislike skin lesions: association with increased serum levels of eosinophil cationic protein and interleukin-5, Arch Dermatol, 133, 203, 10.1001/archderm.1997.03890380075011 Arase, 1990, Eosinophilic polymyositis induced by tranilast, J Dermatol, 17, 182, 10.1111/j.1346-8138.1990.tb01622.x Ellman, 1974, Leukophoresis therapy of hypereosinophilic disorder, JAMA, 230, 1004, 10.1001/jama.1974.03240070038024 Layzer, 1977, Eosinophilic polymyositis, Ann Neurol, 1, 65, 10.1002/ana.410010106 Stark, 1979, Eosinophilic polymyositis, Arch Neurol, 36, 721, 10.1001/archneur.1979.00500470091022 Serratrice, 1980, Relapsing eosinophilic perimyositis, J Rheumatol, 7, 199 Serratrice, 1990, Fasciitis, perimyositis, myositis, polymyositis, and eosinophilia, Muscle Nerve, 13, 385, 10.1002/mus.880130505 Bochner, 1991, Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor, J Allergy Clin Immunol, 88, 629, 10.1016/0091-6749(91)90157-J Sladek, 1983, Relapsing eosinophilic myositis, J Rheumatol, 10, 467 Yonker, 1985, Idiopathic eosinophilic myositis with preexisting fibromyalgia, J Rheumatol, 12, 165 Silberstein, 1987, The regulation of human eosinophil function by cytokines, Immunol Today, 8, 380, 10.1016/0167-5699(87)90214-3 Fujisawa, 1990, Regulatory effect of cytokines on eosinophil degranulation, J Immunol, 144, 642, 10.4049/jimmunol.144.2.642 Weller, 1991, The immunobiology of eosinophils, N Engl J Med, 324, 1110, 10.1056/NEJM199104183241607 Weller, 1994, Eosinophils: structure and functions, Curr Opin Immunol, 6, 85, 10.1016/0952-7915(94)90038-8 Fauci, 1982, The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations, Ann Intern Med, 97, 78, 10.7326/0003-4819-97-1-78 Kazmierowski, 1978, Dermatologic manifestations of the hypereosinophilic syndrome, Arch Dermatol, 114, 531, 10.1001/archderm.1978.01640160009003 Weller, 1994, The idiopathic hypereosinophilic syndrome, Blood, 83, 2759, 10.1182/blood.V83.10.2759.2759 Sanderson, 1992, Interleukin-5, eosinophils, and disease, Blood, 79, 3101, 10.1182/blood.V79.12.3101.3101 Dent, 1990, Eosinophilia in transgenic mice expressing interleukin 5, J Exp Med, 172, 1425, 10.1084/jem.172.5.1425 Fredrikson, 1996, Skin-specific expression of interleukin-5 in transgenic mice: characterization of the resulting leukocyte infiltrate and pathophysiologic responses [abstract], J Invest Dermatol, 106, 937 Egan, 1995, Inhibition of pulmonary eosinophilia and hyperreactivity by antibodies to interleukin-5, Int Arch Allergy Immunol, 107, 321, 10.1159/000237014 Kung, 1995, Involvement of IL-5 in the murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody, Am J Resp Cell Mol Biol, 13, 360, 10.1165/ajrcmb.13.3.7654390 Mori, 1995, Enhanced production and gene expression of IL-5 in bronchial asthma: possible management of atopic diseases with IL-5 specific gene transcription inhibitor